Source: Virtual Congress 2021 – Optimising outcomes of lung transplantation: how to move forward?



Rating:

Share or cite this content

Citations should be made in the following way:
J. Leroux (Strasbourg, France), S. Hirschi (Strasbourg, France), A. Essaydi (Strasbourg, France), A. Bohbot (Strasbourg, France), T. Degot (Strasbourg, France), A. Schuller (Strasbourg, France), A. Olland (Strasbourg, France), R. Kessler (Strasbourg, France), B. Renaud-Picard (Strasbourg, France). Comparison of extracorporeal photopheresis efficacy in treated versus non-treated patients with refractory BOS.. 2916

Member's Comments

No comment yet.

Related content which might interest you: Extracorporeal photopheresis: an effective treatment for pulmonary graft versus host disease Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children Year: 2020 12 month follow-up of lung recipients with chronic allograft dysfunction treated with extracorporeal photopheresis (ECP) Source: Annual Congress 2011 - Improving outcomes after lung transplantation Year: 2011 Efficacy of tacrolimus rescue therapy in refractory acute rejection (AR) after lung transplantation Source: Eur Respir J 2001; 18: Suppl. 33, 298s Year: 2001 LATE-BREAKING ABSTRACT: Long-term survival with extracorporeal photochemotherapy in lung transplant rejection patients not responsive to conventional treatment. Source: International Congress 2014 – Novel approaches in the management of lung transplant candidates and recipients Year: 2014 Efficacy of high-dose leukocytaphereis using extracorporeal circulation through a large leukocyte-removal filter column in patients with refractory asthma Source: Annual Congress 2011 - New treatments for airway disease Year: 2011 Efficacy of traditional and combined therapy in patients with sarcoidosis Source: Eur Respir J 2003; 22: Suppl. 45, 234s Year: 2003 Ulinastatin plus thymosin-α1 as immunotherapy improves survival in patients with sepsis Source: Annual Congress 2009 - Acute lung injury and biomarkers Year: 2009 Comparison of treatment outcomes in community-acquired pneumonia patients treated with beta lactam-macrolide combination versus fluoroquinolone monotherapy Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012 Efficacy of surfactant therapy for ARDS after operations on open heart. Comparison with historical control Source: Eur Respir J 2003; 22: Suppl. 45, 71s Year: 2003 Effect of TLI during azithromycin treatment in patients with BOS after lung transplantation Source: Eur Respir J 2007; 30: Suppl. 51, 174s Year: 2007 Long-term response to prednisone in newly treated patients with pulmonary sarcoidosis Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys Year: 2021 Efficacy and safety of erythropoietic agents in anaemic patients with lung cancer (LC) Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 Short-term efficacy of advanced NSCLC patients receiving anlotinib hydrochloride as the first and second-line treatment Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer Year: 2020 Cost consequences of tiotropium plus existing therapy versus existing therapy alone following one year of treatment in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 5s Year: 2001 The efficacy of salmeterol/fluticasone (SF) for 6-month therapy in severe COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 30s Year: 2006 Efficacy of α-tocoferol in the treatment of patients with pneumonia Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 A matched pairs analysis of long-term outcomes in first-line i.v. epoprostenol or first-line bosentan treated idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Present and future medical management of pulmonary arterial hypertension Year: 2010 Comparing pneumonia incidence in COPD patients treated with or without inhaled corticosteroid Source: Virtual Congress 2021 – Inhaled treatments for COPD: real-world data Year: 2021 Treatment results using low doses of prednisolone, cyclophosphamide and extracorporeal processing of lymphocytes with prednisolone in patients with idiopathic interstitial pneumonia (IIP) Source: Eur Respir J 2003; 22: Suppl. 45, 197s Year: 2003 Efficacy and toxicity of azathioprine plus corticosteroids in 32 patients with chronic persistent sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004